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Abstract
Promyelocytic leukemia oncogenic domains (PODs), also called nuclear domain 10 (ND10), are subnuclear structures that have been
implicated in a variety of cellular processes as well as the life cycle of DNA viruses including papillomaviruses. In order to investigate the
interplay between papillomaviruses and PODs, we analyzed the status of PODs in organotypic raft cultures of human keratinocytes harboring
HPV genome that support the differentiation-dependent HPV life cycle. The number of PODs per nucleus was increased in the presence of HPV
genomes selectively within the poorly differentiated layers but was absent in the terminally differentiated layers of the stratified epithelium. This
increase in PODs was correlated with an increase in abundance of post-translationally modified PML protein. Neither the E2-dependent
transcription nor viral DNA replication was reliant upon the presence of PML. Implications of these findings in terms of HPV's interaction with its
host are discussed.
© 2007 Elsevier Inc. All rights reserved.Keywords: PML; Papillomavirus; Raft cultures; Viral DNA replication; Viral transcriptionIntroduction
Promyelocytic leukemia (PML) oncogenic domains (PODs),
also called PML nuclear bodies (PML-NBs) or nuclear domain
10 (ND10), are subnuclear structures with size ranging from 0.1
to 1.0 μm that are attached to the nuclear matrix. They are
characterized by the presence of PML protein, which is essential
for POD assembly. A number of other nuclear proteins localize to
PODs either constitutively such as Daxx, Sp100 and CREB
binding protein (CBP) or in response to certain stimuli. PODs
have been implicated in a wide variety of cellular processes
including transcriptional regulation, protein modification, DNA
repair, chromatin metabolism, apoptosis, p53 pathways, senes-
cence and interferon response. Mammalian cells commonly
contain 5–30 PODs, depending on the cell type, and the number,
size and the composition of PODs can be altered in response to
stimuli including heat shock, genotoxic insults, interferon
treatment and viral infection (Borden, 2002; Dellaire and
Bazett-Jones, 2004; Eskiw et al., 2003; Everett et al., 1999;⁎ Corresponding author. Fax: +1 608 2622824.
E-mail address: lambert@oncology.wisc.edu (P.F. Lambert).
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doi:10.1016/j.virol.2007.04.032Maul et al., 2000; Pearson and Pelicci, 2001; Regad and Chelbi-
Alix, 2001; Zhong et al., 2000b). The number of PODs is
increased upon interferon treatment due to transcriptional
upregulation of PML and Sp100 (Chelbi-Alix et al., 1995;
Lavau et al., 1995; Stadler et al., 1995). Therefore, PODs have
been hypothesized to participate in cellular defense mechanisms
against incoming pathogens, though the function of PODs (or
PML, Sp100) in the innate immune response remains poorly
understood. Many viruses, particularly DNA viruses, have been
shown to cause disruption of PODs and mutant viruses that lack
the ability to disrupt PODs replicate inefficiently, providing
further support that PODs mediate cellular defense (Ahn and
Hayward, 1997; Chee et al., 2003; Everett, 2001; Korioth et al.,
1996; Leppard and Everett, 1999; Muller and Dejean, 1999;
Puvion-Dutilleul et al., 1995a,1995b). For instance, an immediate
early gene product of herpes simplex virus-1 (HSV-1), ICP-0,
targets PML for the proteosome-dependent degradation (Everett
et al., 1998; Maul et al., 1993). Consistent with the hypothesis
that HSV-1 counteracts cellular defenses mediated by PML or
PODs, the replication defective phenotype of an ICP-0 mutant
HSV-1 can be rescued in human fibroblasts in which PML
expression is stably knocked down, (Everett et al., 2006).
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linked to distinct steps or processes in the life cycle of many
DNA viruses, such as HSV-1, cytomegalovirus (CMV),
adenovirus and simian virus 40 (SV40) (Everett, 2001; Ishov
and Maul, 1996). The genomes of these DNA viruses can be
found in close association with PODs during infection and
proteins encoded by these viruses that regulate transcription
and/or replication of the genomes can associate with compo-
nents of PODs, such as PML, Daxx or Sp100. These
observations have led to the hypothesis that these viruses
associate with PODs in order to support viral transcription and/
or replication of the genome. For instance, plasmids containing
the SV40 origin of DNA replication have been shown to
localize to or nearby to PODs in the presence of SV40 large T
antigen, which is essential for SV40 DNA replication (Tang et
al., 2000). The genome of HSV-1 associates with PODs upon
infection in the time frame when transcription of immediate
early genes takes place; and at later stages of the life cycle, PML
along with the DNA repair machinery is recruited to globular
nuclear domains that are sites of HSV-1 DNA replication and
contain essential viral DNA replication proteins such as the
DNA binding proteins (ICP8 or UL29) and the viral polymerase
(UL30) (Burkham et al., 1998; Everett and Murray, 2005;
Everett et al., 2003; Wilkinson and Weller, 2004).
Papillomaviruses are a group of small nonenveloped viruses
with circular double stranded DNA genomes approximately
8 kbs long that infect the squamous stratified epithelia in
cutaneous or mucosal sites and usually cause hyperproliferative
lesions in a variety of higher vertebrates including humans. A
subset of mucosotropic human papillomaviruses (HPVs),
called high risk HPVs, are frequently associated with human
cancers including cervical cancer, other anogenital cancers and
a subset of head and neck cancers (zur Hausen, 2002). The life
cycle of papillomavirus is tightly linked to the differentiation
process of the host squamous epithelia. HPVs gain access to
and infect basal cells within the squamous epithelia presumably
at sites of wounding and establish their DNA genome as
extrachromosomal replicons at low copies in the host nucleus.
In these undifferentiated, mitotically active cells, a subset of
viral genes called the early genes, are expressed and the viral
DNA is replicated on average once per cell cycle and
efficiently segregated to daughter cells, thereby leading to the
stable maintenance of the viral genome within the infected
tissue. As no progeny virus is made in basal cells, this is
referred to as the nonproductive stage of the life cycle. Once
daughter cells leave the basal compartment and initiate terminal
differentiation, the productive stage of the viral life cycle
begins. Here, viral DNA is amplified, structural or capsid
proteins expressed and progeny viruses assembled (Howley
and Lowy, 2001). The virus encodes at least five early genes
(E1, E2, E5, E6 and E7) that are involved in viral DNA
replication and transcription (E1, E2) (Lambert, 1991) and in
creating a cellular environment that is supportive of the viral
replicative life cycle (E5, E6 and E7) (Fehrmann et al., 2003;
Flores et al., 2000; Genther et al., 2003; Thomas et al., 1999).
Three ‘late’ genes (E1^E4, L1, L2) are selectively expressed in
the terminally differentiated cells. They are involved in viralDNA amplification (E1^E4) (Nakahara et al., 2005; Wilson et al.,
2005) or form the protein capsid (L1 and L2 are the major and
minor capsid protein, respectively) of the progeny virions
(Kirnbauer et al., 1993). Several reports have demonstrated that
early proteins (E1, E2, E6 and E7) as well as late proteins (E1^E4
and L2) associate with PODs or protein constituents of PODs,
suggesting that PODs play an important role in the papillomavirus
life cycle. Based on these studies, it has been hypothesized
that PODs are sites for the initiation of viral infection, DNA
replication and DNA encapsidation (Becker et al., 2003; Bischof
et al., 2005; Day et al., 1998, 2004; Florin et al., 2002; Guccione
et al., 2004; Heino et al., 2000; Roberts et al., 2003; Swindle et al.,
1999).
In this study, we analyzed the status of PODs in cells that
harbor papillomavirus genome extrachromosomally and deter-
mined whether PODs are required for discrete processes the
papillomaviral life cycle. We found that the number of PODs
was increased in cells that harbor papillomaviral genomes, and
that this increase in human keratinocytes was observed
predominantly within undifferentiated cells. Analysis of PML
proteins indicated that the increase in the number of PODs
correlated with increased post-translational modification of
PML. Nevertheless, while we were able to recapitulate the effect
of PML on early steps in infection by papillomavirus, we found
that replication and transcription of transfected papillomaviral
genomes were not dependent upon PML.
Results
PODs are increased within poorly differentiated cells in the
organotypic raft cultures of NIKS cells harboring HPV genome
In order to examine the effect of papillomaviruses on PODs
in the context of the viral life cycle, we analyzed the status of
PODs in the organotypic (raft) cultures harboring HPV genome
extrachromosomally that support the differentiation-dependent
life cycle of papillomaviruses. Sections from paraffin-
embedded rafts of NIKS (normal immortalized keratinocytes,
previously referred to as BC-1-EP/SL), a spontaneously
immortalized line of human foreskin keratinocytes known to
support the HPV life cycle, that do or do not harbor the HPV16,
HPV18 or HPV31 genome were subjected to indirect immuno-
fluorescence (IF) staining using anti-human PML antibody.
Fig. 1 shows representative IF images obtained using confocal
microscopy. PML was detected as nuclear speckles consistent
with the pattern of PODs described in the literature (Maul et al.,
2000). The intensity and the number of PODs was increased in
rafts of NIKS harboring HPV16 genome when compared to
rafts of NIKS not harboring HPV genomes (Fig. 1). This
increase was observed predominantly within the poorly
differentiated basal and parabasal layers of the stratified
epithelia (white boxes in Figs. 1A and B, enlarge images are
shown in Figs. 1C and D) in which the early, nonproductive
stage of the viral life cycle takes place. This same result was
observed in rafts of NIKS harboring HPV31 genomes using an
alternative PML antibody (Supplemental Fig. 1) and in rafts of
NIKS harboring HPV18 genomes (data not shown).
Fig. 1. Immunofluorescence analysis of PODs in rafts that do or do not harbor HPV16 genome. Cross-sections from paraffin-embedded rafts of NIKS cells (A, C, E) or
NIKS cells harboring HPV16 genome (B, D, F) were double stained with anti-human PML rabbit polyclonal antibody and anti-E1^E4 mouse monoclonal antibody as
described in Materials and methods. PML was detected using Alexa 488-conjugated goat anti-rabbit antibody (green) and E1^E4 was detected using Alexa 598-
conjugated goat anti-mouse antibody (red). Nuclei were counterstained with TOTO-3 (blue). All images were analyzed using confocal microscopy (MRC1024, Bio-
Rad/Zeiss). PML was detected as nuclear speckles in nucleus. Enlarged images from the area in basal cell layers (C, D) or granular layers (E, F) are shown. White
boxes in panels A and B indicate the areas shown in the enlarged images panels C–F.
318 T. Nakahara, P.F. Lambert / Virology 366 (2007) 316–329Interestingly, we failed to find PML-positive nuclear speckles
in the granular layers of rafts of NIKS not harboring HPV
genomes (a white box in Fig. 1A, an enlarged image is shown in
Fig. 1E). This suggests that PODs disappear in human
keratinocytes as they terminally differentiate. An alternative
explanation might be that the epitope recognized by the PML ab
used in our immunofluorescence staining shown in Fig. 1 was
masked somehow in the terminally differentiated cells. How-
ever, a similar, selective loss of detection of PML in the
terminally differentiating compartment was observed with a
second monoclonal antibody for PML that recognizes a different
epitope (Supplemental Fig. 1).
The granular layer is the cellular compartment that, in tissues
harboring HPV genomes, supports expression of late viral
proteins and assembly of progeny virus. It has been shown
previously that viral late proteins, E1^E4 and L2 protein, when
overexpressed in heterologous cell types, associate with PML or
PODs (Day et al., 1998; Florin et al., 2002; Roberts et al., 2003).
Therefore, we were interested in knowing if PODs were
specifically retained in those terminally differentiating epithelial
cells supporting the productive stage of the viral life cycle. In
order to analyze the status of PODs specifically in those
terminally differentiating keratinocytes in which the productive
stage of the viral life cycle had been initiated, we performed
double immunofluorescence staining with antibodies to PML
and the late viral protein E1^E4. E1^E4 is known to beexpressed in all cells in which viral DNA amplification, an
initial aspect of the late stage of the viral life cycle, arises
(Middleton et al., 2003; Nakahara et al., 2005). As shown in
Figs. 1B and F, we were not able to detect PODs in E1^E4-
positive cells, indicating that PODs are lost in the differentia-
tion-dependent manner even in the presence of HPV genome.
The viral minor capsid protein L2 protein forms aggregates in
rafts harboring HPV genome that is independent of PODs
PODs have been hypothesized to be sites of papillomaviral
DNA encapsidation (Becker et al., 2003; Florin et al., 2002),
which is a step in the late stage of the viral life cycle the efficiency
of which depends on L2 (Holmgren et al., 2005). However, we
found that PODs are absent in terminally differentiating epithelial
cells including those that express E1^E4 and therefore have
undergone progeny viral DNA amplification, a step that occurs
prior to virus assembly and DNA encapsidation (Fig. 1). This
predicts that the subsequent steps of viral assembly including
DNA encapsidation do not require PODs. In agreement with our
observations, Becker et al. (2004) found that the assembly of
virus-like particles, VLPs, occurs in PML-null MEFs. Interest-
ingly, they also found that L2 still accumulated in nuclear dots in
PML-null MEFs, and they observed that L1 was recruited into
these nuclear dots (Becker et al., 2004). To examine the sub-
cellular localization of L2 in the natural host cells, i.e. terminally
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escence for L2 and PMLon sections from rafts ofNIKS harboring
HPV31 genome (available L2 antibodies for HPV16 do not
efficiently detect L2 in rafts by IF). As shown in Fig. 2, L2 was
detected in small to large nuclear aggregates in the granular layers
and none of these L2-positive cells were positive for PML. These
results indicate that in the natural host cell inwhich virus assembly
occurs, as in PML-nullMEFs, L2 forms aggregates in the absence
of PML or PODs.
The number of PODs is increased two-fold in NIKS cells
harboring extrachromosomally replicating HPV genome
To evaluate more quantitatively whether PODs are increased
within poorly differentiated human keratinocytes cells of raftsFig. 2. Immunofluorescence analysis of PODs and L2 in rafts harboring HPV31
genome. Cross-sections from paraffin-embedded rafts of NIKS cells harboring
HPV31 genome were stained with anti-L2 rabbit polyclonal antibody (A) or
double stained with anti-L2 antibody and anti-human PML mouse monoclonal
antibody (B). L2 was detected with goat anti-rabbit antibody conjugated with
Alexa 488 (green in panel A) or conjugated with Alexa 546 (red in panel B).
PML was detected with goat anti-mouse antibody conjugated with Alexa 488
(green in panel B). Nuclei were counterstained with TOTO-3 (blue). All images
were analyzed using confocal microscopy (MRC1024, Bio-Rad/Zeiss).
Enlarged images for L2-positive cells are shown in top (a, b, e, f) and overall
views of rafts are shown in bottom (c, d, g, h).harboring HPV genomes (Fig. 1), we examined the status of
PODs in NIKS grown on feeders in monolayer, a condition that
maintains keratinocytes in the poorly differentiated state. NIKS
were grown on coverslips with feeder cells for 2 days and
subjected to IF staining using antibodies against PML or Daxx,
both components of PODs. Feeder cells were removed prior to
fixation as described in Materials and methods. Fig. 3A shows
representative IF images of NIKS that do or do not harbor HPV
genomes. Consistent with the observations made in raft
cultures, the intensity and the number of nuclear speckles
detected with antibodies to PML and Daxx was increased in
monolayer cultures of NIKS harboring HPV16, HPV18 or
HPV31 genomes, as compared to monolayer cultures of NIKS
not harboring HPV genomes. We quantified the number of
nuclear speckles positive for PML or Daxx in each population
(Fig. 3B). NIKS harboring HPV genomes contained approxi-
mately two-fold more nuclear speckles than the parental, HPV-
negative NIKS. These differences were statistically significant.
We concluded that the number of PODs was increased in NIKS
harboring extrachromosomal HPV genomes.
We also tested whether the number of PODs was increased in
mouse C127 fibroblasts harboring bovine papillomavirus type 1
(BPV-1) genomes. The number of PML-positive nuclear
speckles was increased in two clones of C127 cells harboring
BPV-1 genome (clone B and ID13; Law et al., 1981; Lowy et
al., 1980) compared to parental, BPV-1-negative C127 cells
(data not shown). Thus, the increased frequency of PODs is a
feature conferred by both animal and human papillomaviruses.
In addition, we compared the number of nuclear speckles
positive for PML or Daxx in clonal populations of cervical
epithelial cells derived from a patient infected with HPV16 in
which the viral genomes exist either as extrachromosomal
replicons (designated as W12E) or integrated into the host
genome (designated as W12I) (Jeon and Lambert, 1995). W12E
cells contained a statistically significant, approximately two-
fold higher number of PML-positive PODs (6.6±1.2 and
6.4±1.8 in clones 20863 and 20850, respectively) compared to
W12I (3.7±0.6, 3.6±0.5 and 2.9±0.7 for clones 20861, 21402
and 20822, respectively) cells. A similar two-fold difference
was observed with Daxx antibody (data not shown). These data
indicated that the extrachromosomal state of the papillomaviral
genome correlates with an increased number of PODs. Taken
together, these IF data demonstrate that papillomaviruses cause
an increase in the number of PODs in the nonproductive stage of
the viral life cycle, possibly in association with extrachromo-
somal viral DNA replication.
Slower migrating forms of PML are increased in the cells
harboring papillomavirus genome
Since PML protein is known to be required for POD
formation, we tested whether the levels of PML protein were
increased in human and mouse cells harboring papillomavirus
genomes. Total cellular protein was isolated in the cell lysis
buffer containing 20 mM NEM which inhibits desumoylation
and an equal amount of the protein lysate was subjected to
Western blot analysis (Fig. 4A). As a control, the protein lysate
Fig. 3. Immunofluorescence analysis of monolayer of NIKS that do or do not harbor HPV genome. (A) Monolayer cultures of NIKS cells or NIKS cells harboring
HPV16 genome, HPV18, HPV31 genomes were subjected to indirect immunofluorescent analysis using anti-human PML antibody (a–d) or anti-human Daxx
antibody (e–h) as described in Materials and methods. PML as well as Daxx was detected using Alexa 488-conjugated goat anti-rabbit antibody (green) and nuclei
were counterstained with TOTO-3 (blue). (B) Quantification of the number of nuclear speckles in NIKS cells that do or do not harbor HPV genome. The numbers of
nuclear speckles positive for PML or Daxx were counted in NIKS cells, four independently generated NIKS cell populations harboring HPV16 genome and two
independent NIKS cell populations each harboring either HPV18 or HPV31 as indicated. The number of nuclear speckles was significantly increased in all NIKS cell
populations harboring HPV genome, compared to parental NIKS cells (pb0.05). P value was evaluated using Wilcoxon rank sum test (two sided).
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post-infection because HSV-1 is known to cause degradation of
PML upon infection (lane 1 in Fig. 4A). Protein lysate was also
isolated from mouse embryonic fibroblasts (MEFs) generated
from either PML-null or PML-sufficient mice (generous gifts
from Dr. Gerd G Maul at The Wistar Institute). In lysates from
NIKS, a major band specific for PML migrating at around
105 kDa as well as several minor bands was detected (left panel,
lanes 1 to 6 in Fig. 4A). All of these bands were detected with a
level significantly reduced in NIKS infected with HSV-1,
confirming that these protein species are PML specific. In
mouse fibroblasts, the major PML-specific band had an
apparent molecular weight slightly larger than 105 kDa. It and
some minor bands were not detected in PML-null MEFs (lane 7
in Fig. 4A). As shown in Fig. 4A, the patterns of migration of
PML proteins were affected by the presence of papillomavirus
genomes (lanes 3–6 compared with lane 2, lanes 10 and 11
compared with lanes 8 and 9). In all cases we saw an increased
abundance particularly of slower migrating forms of PML
(brackets, Fig. 4A) in the human keratinocytes as well as the
mouse fibroblasts harboring papillomavirus genomes. Theseslower migrating forms of PML could represent altered post-
translational modification states of PML (Boddy et al., 1996;
Chang et al., 1995) or alternative isoforms that arise from
differential splicing transcripts. PML encodes three lysines that
are conjugated with small ubiquitin modifier-1 (SUMO-1) and
the conjugation of a SUMO-1 molecule adds the size of the
conjugated proteins each approximately 12 kDa (Dohmen,
2004). Sumoylation of PML is required for proper POD
formation and for recruiting proteins such as Daxx into PODs
(Ishov et al., 1999; Zhong et al., 2000a). This and the facts that
we observed a correlation between the increased number of
PODs and the accumulation of slower migrating forms of PML
led us to suspect that the latter represent sumoylated forms of
PML.
To investigate further the nature of the slower migrating
forms of PMLs, we compared the electrophoretic mobility of
PML in NIKS to that in 293T cells transfected with vectors
expressing individual PML isoforms (Fig. 4B). The expression
vectors encoding each of six isoforms of human PML cDNA,
PML I to VI (Beech et al., 2005) or the empty vector was
transfected into 293T cells and the protein lysate was isolated.
Fig. 4. Western blot analysis for PML in NIKS and C127 cells that do or do not harbor papillomaviral genomes (A). The protein lysate was isolated from cells in the
lysis buffer containing 20 mM of NEM. One hundred micrograms of protein from NIKS cells (lanes 1–6) or 20 μg of mouse cells (lanes 7–11) was electrophoresed
through a 7.5% SDS–polyacrylamide gel and transferred to PVDF membrane. Human PML protein was detected using anti-human PML mouse monoclonal antibody
(top panel: lanes 1–6) and mouse PML protein was detected using anti-mouse PML mouse monoclonal antibody (top panel: lanes 7–11). GAPDH was detected as a
loading control (bottom panels). NIKS cells were infected with HSV-1 at 10 MOI and harvested at 6 h post-infection (lane 1). Two independent NIKS cells populations
harboring HPV16 (lanes 3, 4) or HPV18 (lanes 5, 6) were shown for comparison to parental NIKS cells (lane 2). C127 cells clone B or ID13 (lane 10 or 11,
respectively) were compared to parental C127 cells (lane 9). Mouse embryonic fibroblasts (MEFs) generated from a PML knock out mouse (lane 7; PML-null MEFs)
or from its wild-type counterpart (lane 8; PMLWT MEFs) were included as a negative or positive control for mouse cells. Molecular weight markers are depicted on
left of top panels. A bracket on the right of top panels indicates slower migrating forms of PML described in the text. (B) The expression vector encoding each isoform
of human PML cDNA (PMLI to PML VI) that were FLAG tagged at N-terminus or the empty vector was transfected into 293T cells and the protein lysate was
harvested at 48 h post-transfection. Five micrograms of protein lysate from 293T cells and 100 μg of protein lysate from NIKS cells were electrophoresed.
Exogenously expressed PMLs in 293T cells (lanes 1 to 7) and endogenous PMLs in NIKS cells (lane 8) were detected using anti-human PML antibody (top two
panels). After stripping, the membrane was subjected to immunodetection using anti-FLAG antibody (bottom panel). Molecular weight markers are depicted on right
of each panel.
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of the protein lysate from 293T cells transfected were
electrophoresed together with 100 μg of the protein lysate
from NIKS cells and PML proteins were detected by Western
blot using anti-human PML antibody or anti-FLAG antibody.
As shown in Fig. 4B, the major bands of PML isoform I and II
(the largest predicted isoforms) were detected at size around
105 kDa (lanes 2 and 3 in Fig. 4B). This size was consistent
with the size of the major endogenous PML detected in NIKScells (lane 8 in Fig. 4B: long exposure). As predicted, the major
bands of all other PML isoforms were smaller than 105 kDa
(lanes 4 to 7). Minor bands that migrated slower than the major
bands for each PML isoform likely reflect post-translationally
modified derivatives of the individual PML isoform exogen-
ously expressed. These slower migrating forms (Fig. 4B) were
in the same apparent size range as the slower migrating forms of
PML detected in NIKS harboring HPV genomes (bracket, Fig.
4A). We interpreted these results to indicate that the slower
Fig. 5. E2-dependent transcription assay in HP-3 cells or Hemp cells. A plasmid
encoding full sequence of BPV-1 wild-type genome or mutant BPV-1 genomes
defective for E2TA (BPV-1 E2TA(−)) or E2TR (BPV-1 E2TR(−)) was co-
transfected a reporter plasmid, pBS1073 or pBS1013 into HP-3 cells or Hemp
cells. An empty vector was transfected as a control (no BPV-1). pBS1073
contains four E2 binding sites (E2BS) located upstream of the minimal
thymidine kinase promoter, which drives expression of firefly luciferase;
therefore, luciferase expression from pBS1073 is E2-dependent. pBS1013, a
parental plasmid of pBS1073, which does not contain E2BSs, was used as a
negative control. At 72 h post-transfection, cell lysates were harvested and
luciferase activity was measured as described in Materials and methods. All
transfections were done in triplicate. Average luciferase activity from cells
transfected with the empty vector (no BPV-1) was set at 1. Y-axis indicates fold
increase of a luciferase activity from cells transfected with the indicated BPV-1
DNA. Shown is a representative experiment; this experiment was repeated three
times.
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NIKS cells were post-translationally modified PML. Western
blot analysis for Daxx protein revealed no significant change in
levels of Daxx in NIKS and C127 cells harboring papilloma-
virus genome (data not shown). Thus, the presence of
papillomavirus genome specifically affects PML protein.
PML is not required for the E2-dependent transcription in
BPV-1 transfected cells
Day et al. (2004) recently investigated the trafficking of
papillomavirus particles in infected cells. They found that DNA
encapsidated in papillomavirus pseudovirions together with the
minor capsid protein L2 co-localized to PODs by 24 h post-
infection. They also found an increased expression of either
encapsidated reporter gene or encapsidated viral genome in
PML-null MEFs that had been complimented with a human
PML cDNA. This led the authors to hypothesize that PODs are
destinations for papillomavirus-encapsidated DNAs and con-
tribute to the establishment of viral infections. Using the same
cells Day et al. used, we recapitulated their results using BPV-1
particles (data not shown). Thus, the influence of PML on
papillomavirus infection and the observed increase in PODs in
papillomavirus-positive cells led us to question what specific
viral processes were influenced by PML and PODs.
To investigate in more detail what viral processes might be
dependent upon PODs and specifically PML, we monitored the
efficiency of viral transcription and DNA replication in these
same pair of PML-null MEFs that are or are not complemented
with the human PML cDNA. These cells are called HP3 (PML-
null MEFs transduced with a retrovirus carrying a human PML
cDNA) and Hemp (PML-null MEFs transduced with the empty
retroviral vector) cells. Papillomaviral transcription relies upon
a family of gene products encoded by the viral E2 translational
open reading frame (ORF). The full-length BPV-1 E2 ORF gene
product is called E2 transcriptional activator (E2TA) because it
activates transcription of viral promoters through its ability to
bind the viral genome at multiple copies of a partially
palindromic DNA binding site called E2BS. Two shorter E2
ORF gene products that are generated through initiation of
translation at an internal ATG (E2TR) or through mRNA
splicing (E8E2TR) are transcriptional repressors that can inhibit
the function of E2TA via their ability to bind E2BSs and/or to
form heterodimers with E2TA. We tested the efficiency of
transcription supported by E2TA using a luciferase reporter
assay. The reporter plasmid, pBS1073, encodes four E2BSs in
the upstream of the minimal thymidine kinase promoter which
drives expression of firefly luciferase. pBS1073 was used to
monitor E2TA activity. pBS1013, a parental plasmid to
pBS1073 that does not contain any E2BSs, was used as a
negative control. To provide further verification that we were
monitoring E2TA function in these experiments, we co-
transfected the reporter plasmids not only with a recombinant
plasmid containing the wild-type BPV-1 viral genome but also
with ones carrying mutant BPV-1 genomes disrupted in their
expression of either E2TA or E2TR expression (Lambert et al.,
1988, 1990). To monitor efficiency for the transfections, a GFPexpressing plasmid was included in the transfections. All
transfections were done in triplicate and three independent sets
of transfections were performed to account for experimental
variation. The luciferase activities from cells transfected with
BPV-1 genomes were normalized to that from cells transfected
with an empty vector. As shown in Fig. 5, the luciferase activity
from pBS1073 was increased when the recombinant plasmid
containing the wild-type BPV-1 was co-transfected. As
expected, a minimal luciferase activity was detected from
pBS1013. The BPV-1-dependent induction in luciferase
expressed from pBS1073 in the PML-positive HP-3 cells or
the PML-negative Hemp cells was 8- or 12-fold, respectively.
These increases were not significantly different from each other
(p=0.12), indicating that PML is not required for the E2-
dependent transcription. As predicted, the mutant BPV-1
genome inactivated for E2TA did not support increased
transcription of luciferase from pBS1073 as compared to that
from pBS1013, whereas the E2TR-defective BPV-1 genome led
to heightened E2TA activity. In the later case the similar level of
E2TA-dependent activity was evident in the HP-3 cell and
Hemp cell lines (18- and 21-fold increase, respectively). Similar
results were obtained whether cells were isolated at 48 (data not
shown) or 72 h (Fig. 4) post-transfection. The efficiency of the
transfection in Hemp and HP3 cells was similar based upon
quantification of the frequency of GFP-positive cells (data not
shown). Thus, we concluded that the presence of PML or PODs
does not influence the transcriptional activity of the E2 in
transfected cells.
Fig. 6. Short-term replication of BPV-1 DNA in HP-3 cells or Hemp cells. A
plasmid encoding full sequence of BPV-1 wild-type genome or mutant BPV-1
genome, defective for both E1 and E2 (BPV-1E1(−)E2(−)), was co-transfected
with pGFP-N1 into HP-3 cells (lanes 4–7) or Hemp cells (lanes 8–11). Hirt
DNAwas isolated from cells at 7 days after transfection and subjected to BamHI
and DpnI digestion. Hirt DNA from equal number of cells was electrophoresed
though 0.8% agarose gels and DpnI-resistant BPV-1 DNA was detected by
Southern blot. A plasmid encoding wild-type BPV-1 linearized by BamHI
digestion was loaded for copy number controls (lanes 1–3). No DpnI-resistant
BPV-1 DNAwas detected in Hirt DNA isolated from HP-3 cells and Hemp cells
transfected with E1 and E2 defective BPV-1 transfection (lanes 4, 8), validating
that BPV-1 DNA replication was E1 and E2 dependent. DpnI-resistant DNA
was detected in all three independent transfections of wild-type BPV-1 genome
into either HP-3 (lanes 5–7) or Hemp (lanes 9–11) cells.
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transfected cells
Swindle et al. (1999) reported that, in the presence of HPV
E1 and E2, a plasmid containing an HPV origin of DNA
replication co-localized to or close by nuclear foci containing
PML protein in transiently transfected cells. This finding led the
authors to conclude that papillomaviral DNA replication occurs
at or near these nuclear foci. To investigate whether PML is
required for papillomaviral DNA replication, a recombinant
plasmid carrying either the wild-type BPV-1 genome or a
mutant BPV-1 genome defective in expression of E2 and the
viral DNA helicase E1 (both E1 and E2 are required for initial
BPV-1 DNA replication) (Lambert et al., 1988), was transfected
into HP3 and Hemp cells. A GFP expression vector was
included in the transfections and its expression was monitored
at 24 h post-transfection, allowing us to confirm that the
efficiency of the transfection was comparable among all
samples. Low molecular weight “Hirt” DNA was isolated at
day 7 post-transfection. Hirt DNA from an equal number of
cells was digested with BamHI, which linearizes the BPV-1
plasmid, in the presence or the absence of DpnI, which can
digest only the input, bacterially synthesized DAM-methylated
DNA. Thus, the DpnI-resistant DNA represents DNA that has
replicated in the transfected mammalian cells. Bacterially
synthesized DNA, pGEM-3Z, was added at the time of cell
lysis as an internal control to ensure that the efficiency of DNA
isolation was comparable for individual samples and that DpnI
digestion was complete (data not shown for no DpnI digestion
control). These digested DNAs were subjected to BPV-1-
specific Southern analysis. Three independent transfections
were performed to account for experimental variation. The
results from a representative experiment are shown in Fig. 6.
Similar levels of DpnI-resistant wild-type BPV-1 DNA
accumulated in Hemp and HP3 cells. As predicted, no DpnI-
resistant BPV-1 was observed using the E1/E2 mutant viral
genome, confirming that we were monitoring E1 and E2-
dependent replication. These results indicated that PML and
PODs are not required for viral DNA replication in transfected
cells.
Discussion
The association of several viral proteins of papillomaviruses
with PODs or PML has been reported, the best-studied being
L2, the minor capsid protein that is implicated viral DNA
encapsidation. Several laboratories have reported that L2 is co-
localized with PML in the nucleus and giving the classical
punctate nuclear pattern seen for PODs. Our previous work as
well as work done by Day et al. have shown that L1, a major
capsid protein, as well as E2 protein co-localizes with PML in
the presence of L2, but not in the absence of L2. These results
led to the hypothesis that PODs may provide sites for viral DNA
encapsidation (Becker et al., 2003; Day et al., 1998; Florin et al.,
2002; Heino et al., 2000). These prior studies were not carried
out in the natural host cells in which progeny virus assembly
normally occurs. In the current study, we found that terminallydifferentiating keratinocytes, the host cells in which progeny
virus assembly does occur, did not contain PML-positive
nuclear speckles even in the presence of HPV genomes and that
L2 forms aggregates in the absence of PODs in those terminally
differentiating keratinocytes (Figs. 1 and 2). Thus, we must
conclude that viral DNA encapsidation occurs independent of
PODs or PML. Interestingly, Becker et al. (2004) found that
Daxx, which is detected in a diffuse or occasionally
microdispersed pattern in the nucleus of PML-null cells or in
human fibroblasts in which the expression of PML is knock
down by shRNA (Everett et al., 2006; Zhong et al., 2000a), was
attracted to nuclear aggregates of L2 in the PML-null MEFs.
Recently, it was reported that the localization of L2 with PODs
was dependent on the expression level of L2 as high but not low
levels of L2 resulted in the localization to PODs. Furthermore,
the localization of L2 to PODs was not affected by the treatment
of interferon β that increases PODs via transcriptional
upregulation of PML and Sp100 (Kieback and Muller, 2006).
Taken together with our findings illustrated in Fig. 2, we
hypothesize that L2 protein may self-aggregate and attract
POD-associated proteins into nuclear foci that resemble POD
structures when it is expressed at high level. The direct target of
L2 in forming these POD-like nuclear bodies may be Daxx
protein or other POD-associated proteins but not PML per se.
Since L2 has been indicated to play a key role for viral DNA
encapsidation, this de novo formation of POD-like structures
may be a part of viral assembly processes in the terminally
differentiating cells where L2 is expressed at a high level. It
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Daxx in the terminally differentiating cells in the presence or
the absence of HPV genome to study POD-like structures
(unfortunately, antibodies for Daxx that we tested did not work
on paraffin embedded sections of rafts). An example of de novo
formation of POD-like structures has also been described for
HSV-1-infected cells immediately upon infection (Everett et al.,
2004).
Although we did not observe the detectable influence of HPV
genome on the absence of PODs in terminally differentiating
cells, we did observe that the frequency of PODs was increased
in the basal to intermediate layers of rafts cultures and in
monolayer cultures of NIKS harboring HPV genomes (Figs. 1
and 3) as well as C127 cells harboring BPV-1 genome (data not
shown). Quantification revealed that the number of PODs, using
either abs to PML or Daxx, was approximately two-fold
increased in NIKS harboring HPV genomes. Furthermore,
W12E cells contained two-fold greater numbers of PODs than
W12I cells and the number of PODs inW12I cells was similar to
that of HPV-negative NIKS, indicating that the presence of
extrachromosomally replicating papillomavirus genomes corre-
lates with the increase in numbers of PODs. Both E6 and E7
oncoproteins of HPV16 are selectively expressed in the W12I
cells (Jeon and Lambert, 1995). Therefore, we conclude that
expression of the E6 and the E7 oncogenes is not sufficient to
account for the increased number of PODs.
Western blot analysis showed that slower migrating forms of
PMLs were concomitantly increased in NIKS cells as well as
C127 cells harboring papillomavirus genomes and that the
slower migrating forms of PML were likely post-translationally
modified forms of PMLs (Fig. 4). Sumoylation of PML is
required for proper POD formation. In PML-null MEFs, POD
related proteins such as Daxx and Sp100 fail to localize to
similar nuclear structures. Introduction into these cells of the
mutant PML that lacks all three sumoylation sites does not
rescue POD formation whereas the introduction of the wild-type
PML does (Zhong et al., 2000a). Given this requirement of
sumoylation for POD formation we raise the possibility that
sumoylation of PML is enhanced and/or desumoylation of the
PML is suppressed in the presence of extrachromosomal
papillomavirus genomes.
Little is known about what controls sumoylation of PML.
The number of PODs can change during the cell cycle,
increasing in S phase and decreasing during mitosis, and in
response to cellular stresses. Although the mechanisms under-
lining these processes has not been clearly elucidated, they
appear to be in part mediated by phosphorylation and
subsequent sumoylation or desumoylation of PML. Everett et
al. (1999) have shown that sumoylated forms of PML are absent
and instead a phosphatase sensitive form of PML newly appears
in mitotic cells, indicating that PML is desumoylated and
phosphorylated prior to or during mitosis. They also showed
that the treatment of a phosphatase inhibitor to interphase cells
facilitated desumoylation of PML, suggesting that PML is
phosphorylated and subsequently desumoylated in mitosis
(Everett et al., 1999). In contrast, treatment with arsenic tri-
oxide (AS2O3) induces sumoylation of PML in a variety ofcells, and in APL cells, in which PODs are normally disrupted,
AS2O3 restores PODs (Zhu et al., 1997; Bischof et al., 2005).
Hayakawa and Privalsky (2004) reported that AS2O3 induced
phosphorylation of PML through mitogen activated kinase
(MAPK) pathways and increased phosphorylation of PML was
associated with increased sumoylation of PML. Viral E5 protein
of HPV16 as well as BPV-1 has shown to activate a growth
factor receptor, epidermal growth factor receptor (EGFR) or
platelet-derived growth factor receptor (PDGF-R), respectively,
resulting in the enhancement of MAPK-dependent signal
transduction pathways (Crusius et al., 1997, 2000; Petti et al.,
1991). Therefore, it is possible that the E5 induces sumoylation
of PML and subsequent formation of PODs by activating the
MAPK pathways. This is consistent with the observation that
W12E cells contain greater numbers of PODs than W12I cells,
in which the E5 expression is lost due to integration (Jeon and
Lambert, 1995). However, it is also relevant to note that long-
term treatment with AS2O3 eventually results in the proteo-
some-mediated degradation of PML. Therefore, if the consti-
tutive activation of MAPK pathways by E5 induces
sumoylation and subsequent increase of PODs in cells
harboring papillomavirus genome, there must be other mechan-
isms provided by the virus to suppress subsequent degradation
of the PML.
Direct interaction of HPV E6 and/or E7 with several
isoforms of PML has been reported. Bischof et al. (2005)
have shown that HPV16, HPV11 or HPV6b E7 co-immuno-
precipitates with all isoforms of the PML tested and that these
E7 proteins, but not the E6 proteins from these same HPVs, can
inhibit PML IV-induced senescence. In contrast, Guccione et al.
(2004) have reported that HPV11 as well as HPV18 E6 protein
co-immunoprecipitates with PML I to IV and can inhibit PML
IV-induced senescence. In those studies, the consequence of
the E7 or the E6 interaction with PML isoforms, other than
in the context of PML IV-induced senescence, was not ad-
dressed. It is possible that the interaction of the E6 and/or the
E7 protein with some isoforms of PML may provide an
additional mechanism that facilitates the increase in the number
of PODs in the presence of E5, but clearly from our PML IF
results with W12I cells, the expression of E6 and E7 alone is not
sufficient.
Whereas the above discussion considers the potential role of
viral oncoproteins in causing the increased frequency of PODs,
our data are also consistent with the alternative hypothesis that
some intrinsic cellular responses to extrachromosomal viral
DNA is responsible for the observed increase in PODs. Jul-
Larsen et al. (2004) found that newly synthesized viral DNA in
cells infected with SV40 or polyomavirus BK (BKV) accu-
mulated at or near to PODs and that this sequestration of the
DNA to PODs was dependent on active viral DNA replication.
A significant portion of the accumulated DNA was single
stranded (ssDNA) leading these investigators to hypothesize
that the viral genomes are recruited to PODs as a part of a DNA
damage response (Jul-Larsen et al., 2004). Indeed, ssDNA is
also recruited to PODs upon UVexposure and depletion of PML
sensitizes cells to UV-induced apoptosis, suggesting that PODs
are processing sites for single stranded, damaged DNA (Boe et
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chromosomally replicating papillomavirus DNA also is asso-
ciated with PODs and this is driven by DNA damage responses.
Consistent with this hypothesis, Swindle et al. (1999) observed
that E1 and E2 proteins of HPV11 co-localize with a plasmid
containing the replication origin of HPV11 in or juxtaposed to
nuclear foci containing PML in transient replication experi-
ments and that this co-localization was not observed in the
absence of the ori sequence. The number of PODs increases
upon DNA damage. This increase has been attributed in part to
p53-dependent transcriptional upregulation of PML (Borden,
2002; Dellaire and Bazett-Jones, 2004; Guo et al., 2000). It has
also been shown that PML is phosphorylated by DNA damage
checkpoint kinase Chk2 within 1 h of irradiation (although
protein levels of PML are not changed) and that phosphoryla-
tion of PML by Chk2 is abrogated in the absence of ataxia
telangiectasia-mutated (ATM) (Yang et al., 2002). Indeed,
Dellaire et al. (2006) reported that the initial increase of PODs
upon irradiation was independent of p53 as well as protein
synthesis and new PODs were formed from preexisting PODs
by fission. Furthermore, they showed that this increase of PODs
was delayed or inhibited by a loss of function of Niimegen
breakage syndrome (NBS)-1, ATM, Chk2 and ATR (ATM and
Rad3 related), all of which have been detected in PODs
constitutively or induced upon DNA damage (Dellaire et al.,
2006). Other DNA repair proteins such as BLM, a RecQ DNA
helicase, have been detected in PODs (Sanz et al., 2000;
Yankiwski et al., 2001). It is therefore interesting to consider the
possibility that extrachromosomally replicating papillomaviral
DNA molecules because they may accumulate single stranded
regions of DNA as does polyomavirus DNA, or single or double
stranded breaks (Taylor et al., 2003), could elicit a cellular DNA
damage response that in turn induces the number of PODs. Such
a DNA damage response would ultimately be over-ridden by
the action of the viral oncoproteins E6 and E7, or in the case of
polyomaviruses, large T antigen, which can inhibit DNA
damage responses (Ahuja et al., 2005; Helt and Galloway, 2003;
Munger et al., 2004). Thus, while initial DNA damage responses
that can lead to the induction of PODs may be intact in cells
harboring extrachromosomal viral genomes, the intended
consequence of this response in terms of eliciting a functional
DNA damage response is over-ridden by the viral oncoproteins.
Thus, it is perhaps not surprising that neither we (Fig. 6) nor Jul-
Larsen et al. (2004) in their studies on polyomavirus found
any influence of PML-status on the efficiency of viral DNA
replication.
A number of reports have indicated that the PML can
influence transcription in a positive or a negative manner. For
instance, the overexpression of PML resulted in transcriptional
activation of major histocompatibility complex (MHC) class I
transporter TAP-1 (Zheng et al., 1998) and the glucocorticoid
receptor (Lin et al., 2003), whereas it caused the transcriptional
repression of EGFR (Vallian et al., 1998). This transcriptional
regulation is mediated by the interaction of PML with
transcriptional factors such as Daxx, a repressor for the
glucocorticoid receptor, and Sp-1, an activator for the EGFR.
Block et al. have recently shown that the subnuclear targeting ofreporter plasmids to PODs results in increased or reduced
expression of reporters in a promoter-dependent manner (Block
et al., 2006). The results of Day et al. (2004) and our
confirmatory experiments (data not shown) indicate that
targeting the BPV-1 genome to PODs upon infection enhances
initial transcription of viral early genes, which is mediated by
enhancer elements found in the long control region (LCR).
However, we also observed that PML does not have a direct role
on the activity of the viral E2 transactivator (Fig. 5), which is
presumably expressed at times post-initial infection. Thus, the
importance of PML and PODs in papillomavirus transcription
may be transient in nature.
Materials and methods
Tissue culture and virus infection
NIKS were maintained at subconfluence onto mitomycin C
treated m1 3T3 feeder cells in F medium with all supplements as
previously described (Lambert et al., 2005). C127 cells were
cultured in Dulbecco's Modified Eagle Media (D-MEM,
Invitrogen Co., Carlsbad, CA) containing 10% fetal bovine
serum (FBS), penicillin and streptomycin (100 μg/ml). HP-3
cells and Hemp cells were cultured in media containing G418
(500 μg/ml) and Hygromycin B (400 μg/ml) as previously
reported (Day et al., 2004). NIKS were plated at 1×106 cells in
10-cm tissue culture plate without feeder cells in low calcium F
medium with all supplements (Lambert et al., 2005) on the day
before HSV-1 infection. NIKS were incubated in 2 ml of low
calcium F medium containing HSV-1 KOS strain (a kind gift
from Dr. Curtis R. Brandt at University of Wisconsin-Madison)
at a multiplicity of infection (MOI) of 10 for 2 h at 37 °C to
allow the viruses to attach, briefly washed and incubated in 5 ml
of freshly replaced low calcium F medium with all supplements
for subsequent 6 h until harvesting.
Indirect immunofluorescence
NIKS were plated on coverslips with feeder cells and
cultured in monolayer for 2 days before the staining. Feeder
cells were removed by incubating cells in 0.02% EDTA/
phosphate-buffered saline (PBS) prior to fixation. NIKS were
fixed in 4% paraformaldehyde (PFA) in PBS for 15 min at room
temperature and washed with PBS three times for 5 min.
Subsequently, cells were incubated in 0.01% Triton-X 100 in
PBS for 15 min at room temperature and washed with PBS three
times for 5 min before proceeding with immunostaining. Cross-
sections of rafts on plus coated slides were deparaffinized in
xylene, rehydrated using a serial grade of ethanol and then
microwaved in 10 mM citrate buffer pH 6.0 for 20 min for
antigen unmasking before proceeding immunostaining as
previously described (Nakahara et al., 2005). The indirect
immunofluorescence staining was done as follows. Samples
were incubated in a blocking solution (3% bovine serum
albumin in PBS) for 30 min at room temperature and then
incubated with a primary antibody diluted in the blocking
solution for over night at 4 °C. Samples were washed with PBS
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fluorophore-conjugated secondary antibody diluted in PBS for
30 min at room temperature. NIKS grown on coverslips were
mounted onto slides with the fluorescence mounting medium
(Vector Lab., Burlingame, CA), added 2 μM of TOTO-3
(Invitrogen) and analyzed using confocal microscopy (MRC-
1024, Bio-rad/Zeiss, Thornwood, NY). Rafts were sealed in the
mounting media added 2 μM of TOTO-3 with coverslips and
analyzed. Antibodies used for indirect immunofluorescence
were followings. Anti-human PML rabbit polyclonal antibody
(H-238, Santa Cruz Biotechnology Inc., Santa Cruz, CA) at
1:100 dilution, anti-human PML monoclonal mouse antibody
(PG-M3, Santa Cruz) at 1:200 dilution, anti-human Daxx rabbit
polyclonal antibody (M-112, Santa Cruz) at 1:100 dilution, anti-
E1^E4 monoclonal antibody at 1:20 dilution and anti-HPV31
L2 rabbit polyclonal antibody at 1:500 dilution. Alexa Fluor
488 goat anti-rabbit antibody (Invitrogen) as a secondary
antibody to detect hPML or Daxx at 1:500 dilution and Alexa
Fluor 594 goat anti-mouse antibody as a secondary antibody
detect E1^E4 at 1:500 dilution. To quantify the number of PML
or Daxx-positive nuclear speckles, the number of nuclear
speckles was counted over 200 cells from 10 to 20 images that
were randomly chosen for individual NIKS populations. The
total number of nuclear speckles per image was divided by the
total number of cells per image to derive the average number of
the nuclear speckles per cell. The statistical analysis was
performed using the Wilcoxon rank sum test (two sided).
Western blotting
Cells were washed in ice-cold PBS twice and scraped off in
ice-cold lysis buffer (50 mM Tris pH7.4, 150 mL NaCl, 1 mM
EDTA, 1 mM phenylmethysulfonyl, 1 μg/ml leupeptin, 1 μg/ ml
pepstatin, 1 mM NaF, 1% Nonidet-40, 0.5% deoxycholate,
0.5% Sodium dodecyl sulfate, SDS) containing 20 mM N-
ethylmaleimide (Sigma-Aldrich, St. Louis, MO) and then
incubated on ice for 30 min. The detergent soluble fraction
was separated from the insoluble material by centrifugation at
14,000 rpm for 15 min, 4 °C (Eppendorf Model 5415C
Microcentrifuge). Total protein concentration of the soluble
fraction was measured using DC protein assay kit instructed as
manufacture's protocol (Bio-Rad, Hercules, CA). Equal amount
of protein was mixed with an appropriate volume of 6× SDS
loading buffer (1×; 62.5 mM Tris–HCl pH6.8, 10% glycerol,
2% SDS, 0.02% bromophenol blue) containing 100 mM DTT
and boiled for 5 min. Protein samples were electrophoresed
through an SDS–7.5% polyacrylamide gel (ready-made gel,
Bio-Rad) and transferred onto PVDF membrane (Milipore,
Billerica, MA). The membrane was blocked with 5% skimmed
milk in PBS-T (PBS containing 0.1% Tween-20) for 1 h at room
temperature and incubated overnight at 4 °C with a primary
antibody diluted in the blocking solution. The membrane was
washed with PBS-T three times for 10 min at room temperature
and incubated for 1 h at room temperature with a secondary
antibody (peroxidase-conjugated anti-mouse IgG, Jackson
ImmunoResearch, cat. #715-035-150, West Grove, PA) diluted
1:10,000 in the blocking solution. The membrane was againwashed with PBS-T three times for 10 min each at room
temperature and antibody conjugates were detected using ECL
plus kit (GE healthcare, Piscataway, NJ) according to the
manufacture's instruction. To reuse membranes, they were
stripped by agitating in the stripping buffer (62.5 mM Tris–HCl
pH 6.7, 2% SDS, 100 mM β-mercaptoethanol) for 25 min at
room temperature and washed with PBS-T three times for each
5 min. After stripping, membranes were blocked in the blocking
buffer for overnight at 4 °C, then incubated with the alternative
primary antibody. Primary antibodies used included anti-human
PML mouse monoclonal antibody (clone IB9, MBL, Woburn,
MA) at 1:500 dilution, anti-mouse PML mouse monoclonal
antibody (clone 36.1-104, Upstate/Milipore, Billerica, MA) at
1:500 dilution, anti-GAPDH mouse monoclonal antibody (6C5,
Chemicon/Milipore) at 1:50,000 dilution and anti-FLAGmouse
monoclonal antibody (M2, Sigma-Aldrich) at 1:500. To
compare the migration pattern of each PML isoform, the
expression vector encoding the FLAG tagged human PML or
the empty vector control (provided by Dr. Keith N. Leppard;
Beech et al., 2005) was transfected into 293T cells using
Lipofectamine 2000 (Invitrogen) according to the manufac-
ture's instruction. Forty-eight hours after transfection, the
protein lysate was isolated as described above.
Luciferase assay
The luciferase reporter plasmid, pBS1013 or pBS1073 (Kim
et al., 2003), and the recombinant plasmids encoding the wild-
type BPV-1 (p146-2; Yang et al., 1985) or mutant BPV-1 (p771-
2 (Lambert et al., 1988) or p1472-1 (Lambert et al., 1990))
genome were co-transfected into the mouse fibroblast cell lines,
Hemp and HP3, to monitor the levels of E2-dependent tran-
scription in the absence or the presence of PML, respectively.
Cells were plated on 6-well tissue culture plates in 10% FBS in
D-MEM media without antibiotics at 2×105 cells/well the day
before transfection. One microgram of pBS1013 or pBS1073,
1 μg of pEGFP-N1 (Clontech, Mountain View, CA) and 4 μg of
a BPV-1 encoding plasmid or an empty vector were mixed with
30 μl of Superfect transfection reagent (Qiagen, Valencia, CA)
in 100 μl of Opti-MEM (Invitrogen) and incubated for 15 min at
room temperature. The cell culture media were removed and
replaced with the DNA-Superfect in 500 μl of 10% FBS in D-
MEM. After incubation for 4 h, the media containing the
transfection complex were removed and replaced with the fresh
cell culture media (10% FBS in D-MEM containing G418 and
Hygromycin B). Seventy-two hours after the transfection, cells
were washed twice with PBS and lysed in 200 μl of a luciferase
cell culture lysis buffer (Promega, Madison, WI). Twenty
microliters of cell lysate was mixed with 100 μl of a luciferase
assay substrate (Promega, Madison, WI) and the relative light
unit (RLU) was measured by a luminometer (BD Biosciences,
San Jose, CA). Protein concentration in cell lysate was
measured using DC protein assay kit to normalize RLU per
microgram protein for each sample. All transfections were done
triplicate and three independent sets of experiments were
performed. Statistical analysis was done using the two-sided
Wilcoxon ran sum test.
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Transfection was done using a Nucleofector as per
manufacture's instruction using the MEF 2 Nucleofector kit,
(Amaxa Inc., Gaithersburg, MD). HP-3 cells and Hemp cells
were plated on 15-cm tissue culture plates at 5×105 cells/plate
2 days before transfection. Cells were removed by trypsin
treatment and the number of cells was counted. Cells (1×106)
were mixed with 100 μl of a transfection solution and 4 μg of
the recombinant plasmid encoding the wild-type BPV-1 or a
mutant BPV-1 deficient for E1 and E2 (p1308-1 Lambert et al.,
1988) together with 1 μg of pEGFP-N1. Transfection was done
using the program T-20. Cells were placed back on 10-cm
tissue culture plates and cultured for 7 days. Low molecular
weight Hirt DNA, was extracted from cells as described
previously (Hirt, 1967). Two nanograms of bacterially
synthesized pGEM-3Z (Promega) was added to lysis solution
to compare efficiency of DNA isolation among samples and to
monitor completion of DpnI digestion. Hirt DNA isolated
from an equal number of cells was digested with BamHI with
or without DpnI for 8 h at 37 °C and electrophoresed through a
0.8% agarose gel. The gel was transferred to a nylon
membrane (Hybond-N, GE healthcare) and subjected to
BPV-specific Southern blot as previously described (Lambert
et al., 1990).
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